Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glycon Biochemicals is a specialized biotechnology company based in Germany that focuses on the synthesis and production of high-quality carbohydrates and glycotechnology products. The company provides a comprehensive range of specialty chemicals, including enzyme substrates, oligosaccharides, and glycoconjugates, which are essential for research, diagnostics, and pharmaceutical development. Glycon serves a global clientele in the life sciences industry through both catalog sales and custom synthesis services tailored to specific client needs. Their expertise in carbohydrate chemistry allows for the development of complex molecules used in studying glycosylation and protein-sugar interactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glycon Biochemicals.